Candido E. Rivera

3.8k total citations
50 papers, 1.8k citations indexed

About

Candido E. Rivera is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Candido E. Rivera has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 27 papers in Hematology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Candido E. Rivera's work include Chronic Lymphocytic Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Platelet Disorders and Treatments (9 papers). Candido E. Rivera is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Platelet Disorders and Treatments (9 papers). Candido E. Rivera collaborates with scholars based in United States, Canada and Puerto Rico. Candido E. Rivera's co-authors include Ruben A. Mesa, Neal S. Young, Srđan Verstovšek, Jaroslaw P. Maciejewski, Craig B. Reeder, Betsy LaPlant, Thomas E. Witzig, Ayalew Tefferi, William R. Macon and Julian Halcox and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Candido E. Rivera

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Candido E. Rivera United States	19	858	827	551	392	361	50	1.8k
John Camoriano United States	27	735 0.9×	946 1.1×	714 1.3×	270 0.7×	880 2.4×	66	2.5k
Kristina Carlson Sweden	28	1.3k 1.6×	251 0.3×	987 1.8×	555 1.4×	988 2.7×	76	2.5k
Bruno Royer France	27	1.1k 1.3×	741 0.9×	1.3k 2.4×	414 1.1×	623 1.7×	84	2.5k
Rik Schots Belgium	15	1.1k 1.3×	446 0.5×	570 1.0×	751 1.9×	999 2.8×	37	2.0k
Parameswaran Venugopal United States	21	1.1k 1.2×	482 0.6×	684 1.2×	339 0.9×	412 1.1×	130	1.9k
Maro Ohanian United States	24	1.2k 1.4×	528 0.6×	678 1.2×	130 0.3×	306 0.8×	120	1.8k
Maria Antonietta Aloe Spiriti Italy	20	1.0k 1.2×	598 0.7×	483 0.9×	247 0.6×	235 0.7×	67	1.5k
David M. Ross Australia	28	2.6k 3.0×	2.1k 2.6×	408 0.7×	346 0.9×	482 1.3×	143	3.0k
Ryuichi Kamiyama Japan	24	658 0.8×	270 0.3×	548 1.0×	384 1.0×	435 1.2×	75	1.8k
F. Maloisel France	18	590 0.7×	225 0.3×	396 0.7×	184 0.5×	294 0.8×	61	1.3k

Countries citing papers authored by Candido E. Rivera

Since Specialization

Citations

This map shows the geographic impact of Candido E. Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candido E. Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candido E. Rivera more than expected).

Fields of papers citing papers by Candido E. Rivera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candido E. Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candido E. Rivera. The network helps show where Candido E. Rivera may publish in the future.

Co-authorship network of co-authors of Candido E. Rivera

This figure shows the co-authorship network connecting the top 25 collaborators of Candido E. Rivera. A scholar is included among the top collaborators of Candido E. Rivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candido E. Rivera. Candido E. Rivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ashrani, Aneel A., Michelle A. Elliott, C. Christopher Hook, et al.. (2024). Assessment of Classical Hematologists and Hematology-Focused Fellowship Programs at NCI-Designated Cancer Centers: Implications for Addressing Workforce Shortages and Enhancing Mentorship Opportunities. Blood. 144(Supplement 1). 613–613.

Ritchie, Charles, et al.. (2021). Deep vein thrombosis in the setting of Klippel-Trenaunay syndrome and sirolimus treatment. Journal of Vascular Surgery Cases and Innovative Techniques. 7(3). 524–528. 1 indexed citations

Stancampiano, Fernando F., et al.. (2021). Hemophagocytic Lymphohistiocytosis for the Internist and Other Primary Care Providers. Journal of Primary Care & Community Health. 12. 3667739324–3667739324. 2 indexed citations

Vélez, Miguel González, Carolyn Mead‐Harvey, Heidi Kosiorek, et al.. (2020). Relationship of Area-Level Socioeconomic Status Indicators and Nutritional Anemias: Analysis of Folate, Vitamin B12, and Iron Deficiencies. Blood. 136(Supplement 1). 16–17. 1 indexed citations

Vishnu, Prakash, et al.. (2018). Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers. BMJ Case Reports. 2018. bcr–2018. 2 indexed citations

Oh, Stephen T., Moshe Talpaz, Aaron T. Gerds, et al.. (2018). Hepcidin Suppression By Momelotinib Is Associated with Increased Iron Availability and Erythropoiesis in Transfusion-Dependent Myelofibrosis Patients. Blood. 132(Supplement 1). 4282–4282. 4 indexed citations

Palmer, William C., Prakash Vishnu, William Sánchez, et al.. (2018). Diagnosis and Management of Genetic Iron Overload Disorders. Journal of General Internal Medicine. 33(12). 2230–2236. 32 indexed citations

Dholaria, Bhagirathbhai, Prakash Vishnu, Vivek Roy, et al.. (2017). DA.R-EPOCH Vs. R-CHOP for High-Risk Diffuse Large B- Cell Lymphoma: The Mayo Clinic Florida Experience. Blood. 130. 1572–1572.

Gupta, Vikas, Ruben A. Mesa, Michael W. Deininger, et al.. (2016). A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis. Haematologica. 102(1). 94–102. 77 indexed citations

10.

Nowakowski, Grzegorz S., Betsy LaPlant, William R. Macon, et al.. (2014). Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study. Journal of Clinical Oncology. 33(3). 251–257. 268 indexed citations

11.

Tefferi, Ayalew, Stacie Hudgens, Ruben A. Mesa, et al.. (2014). Use of the Functional Assessment of Cancer Therapy−Anemia in Persons with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia. Clinical Therapeutics. 36(4). 560–566. 26 indexed citations

12.

Chitta, Kasyapa S., Aneel Paulus, Sharoon Akhtar, et al.. (2013). Development Of a Human IgM Secreting Model Of Rpci-WM1 Through Xenografting In SCID Mice For In Vivo Drug Evaluation. Blood. 122(21). 3081–3081. 1 indexed citations

13.

Peterson, Jennifer, et al.. (2012). Hodgkin lymphoma of the Maxillary Sinus: An Unusual Occurrence. Ear Nose & Throat Journal. 91(1). E16–E19. 6 indexed citations

14.

Nowakowski, Grzegorz S., Betsy LaPlant, Thomas M. Habermann, et al.. (2011). Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study. Leukemia. 25(12). 1877–1881. 77 indexed citations

15.

Tefferi, Ayalew, Srđan Verstovšek, G. Barosi, et al.. (2008). Pomalidomide Therapy in Anemic Patients with Myelofibrosis: Results from a Phase-2 Randomized Multicenter Study. Blood. 112(11). 663–663. 5 indexed citations

16.

Mesa, Ruben A., John Camoriano, Susan M. Geyer, et al.. (2007). A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia. Leukemia. 21(9). 1964–1970. 26 indexed citations

17.

Halcox, Julian, Gloria Zalos, Rita Mincemoyer, et al.. (2002). The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. Journal of the American College of Cardiology. 40(7). 1232–1240. 213 indexed citations

18.

Falik‐Zaccai, Tzipora C., Yair Anikster, Candido E. Rivera, et al.. (2001). A New Genetic Isolate of Gray Platelet Syndrome (GPS): Clinical, Cellular, and Hematologic Characteristics. Molecular Genetics and Metabolism. 74(3). 303–313. 33 indexed citations

19.

Rivera, Candido E., et al.. (2001). Identification of a new mutation in platelet glycoprotein IX (GPIX) in a patient with Bernard–Soulier syndrome. British Journal of Haematology. 112(1). 105–108. 22 indexed citations

20.

Ikonomi, Pranvera, Candido E. Rivera, Michael Riordan, et al.. (2000). Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation. Experimental Hematology. 28(12). 1423–1431. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact